Meningitis Vaccine Project

US Scientists Honored in Dubai by Hamdan Medical Award

Retrieved on: 
Thursday, November 24, 2022

DUBAI, UAE, Nov. 24, 2022 /PRNewswire/ -- The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place on 23rd November at the Museum of the Future.

Key Points: 
  • DUBAI, UAE, Nov. 24, 2022 /PRNewswire/ -- The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place on 23rd November at the Museum of the Future.
  • Prof. Marc LaForce was honoured as the winner of the Hamdan International Award for Medical Research Excellence for the topic of the Prevention of Infectious Diseases.
  • Prof. David D Ho was presented with the Hamdan International Award for Medical Research Excellence for the topic of Immunity.
  • William Novick was awarded with the Hamdan Award for Volunteers in Humanitarian Medical Services.

US Scientists Selected for the Three Highest Medical Awards by Hamdan Medical Award

Retrieved on: 
Wednesday, October 19, 2022

The ceremony will honor these scientists and 11 other personalities and organizations from Australia, Saudi Arabia, and the United Arab Emirates.

Key Points: 
  • The ceremony will honor these scientists and 11 other personalities and organizations from Australia, Saudi Arabia, and the United Arab Emirates.
  • Prof. Marc LaForce was announced as the winner of the Hamdan International Award for Medical Research Excellence for the topic of the Prevention of Infectious Diseases.
  • The Award announced Prof. David D Ho as the winner of the Hamdan International Award for Medical Research Excellence for the topic of Immunity.
  • William Novick was announced as the Hamdan Award for Volunteers in Humanitarian Medical Services winner.

Outlook on the Meningococcal Vaccines Global Market to 2030 - Increasing Immunization Programs and Government Initiatives is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 14, 2022

The global meningococcal vaccines market size is expected to reach USD 4.92 billion by 2030, registering a CAGR of 6.2%.

Key Points: 
  • The global meningococcal vaccines market size is expected to reach USD 4.92 billion by 2030, registering a CAGR of 6.2%.
  • In addition, rising FDA approval for meningococcal vaccines is expected to boost the growth.
  • The increase in approval of novel vaccines is expected to improve meningococcal prevention which in turn, is anticipated to drive the market.
  • Initiatives undertaken by the government to combat the rising incidence of the disease are anticipated to boost the meningococcal vaccine market growth.